S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
NASDAQ:MBRX

Moleculin Biotech (MBRX) Earnings Date, Estimates & Call Transcripts

$0.43
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$0.41
▼
$0.44
50-Day Range
$0.38
▼
$0.68
52-Week Range
$0.34
▼
$1.65
Volume
52,103 shs
Average Volume
166,809 shs
Market Capitalization
$12.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 9Estimated
Actual EPS
(Aug. 11)
-$0.20 Beat By $0.08
Consensus EPS
(Aug. 11)
-$0.28
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MBRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MBRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Moleculin Biotech Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.29)($0.29)($0.29)
Q2 20231($0.29)($0.29)($0.29)
Q3 20231($0.30)($0.30)($0.30)
Q4 20231($0.32)($0.32)($0.32)
FY 20234($1.20)($1.20)($1.20)

MBRX Earnings Date and Information

Moleculin Biotech last posted its quarterly earnings data on August 11th, 2023. The reported ($0.20) earnings per share for the quarter, beating analysts' consensus estimates of ($0.28) by $0.08. Moleculin Biotech has generated ($1.02) earnings per share over the last year (($1.02) diluted earnings per share). Earnings for Moleculin Biotech are expected to grow in the coming year, from ($0.94) to ($0.83) per share. Moleculin Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off prior year's report dates.

Moleculin Biotech Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/9/2023
Estimated)		------- 
8/11/2023Q2 2023($0.28)($0.20)+$0.08($0.20)--
5/11/2023Q1 2023($0.25)($0.28)($0.03)($0.28)--
3/22/2023Q4 2022($0.28)($0.24)+$0.04($0.24)--
11/10/2022Q3 2022($0.27)($0.30)($0.03)($0.30)--
8/15/2022Q2 2022($0.25)($0.24)+$0.01($0.24)--
5/11/2022Q1 2022($0.21)($0.24)($0.03)($0.24)--
3/25/2022Q4 2021($0.21)($0.17)+$0.04($0.25)--
11/11/2021Q3($0.20)($0.15)+$0.05($0.15)--
8/10/2021Q2($0.1870)($0.15)+$0.0370($0.23)--
5/11/2021Q1 2021($0.23)($0.20)+$0.03($0.20)--
3/23/2021Q4 2020($0.58)($0.26)+$0.32---
11/19/2020Q3($0.5580)($0.36)+$0.1980($0.06)--  












Moleculin Biotech Earnings - Frequently Asked Questions

When is Moleculin Biotech's earnings date?

Moleculin Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off last year's report dates. Learn more on MBRX's earnings history.

Did Moleculin Biotech beat their earnings estimates last quarter?

In the previous quarter, Moleculin Biotech (NASDAQ:MBRX) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.28) by $0.08. Learn more on analysts' earnings estimate vs. MBRX's actual earnings.

How much profit does Moleculin Biotech generate each year?

Moleculin Biotech (NASDAQ:MBRX) has a recorded net income of -$29.02 million. MBRX has generated -$1.02 earnings per share over the last four quarters.

What is Moleculin Biotech's EPS forecast for next year?

Moleculin Biotech's earnings are expected to grow from ($0.94) per share to ($0.83) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:MBRX) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -